Combination Therapy of Gefitinib and Korean Herbal Medicines Could be a Beneficial Option for Patients with Non-Small-Cell Lung Cancer
Journal: Journal of Pharmacopuncture (Vol.19, No. 3)Publication Date: 2016-09-30
Authors : Kangwook Lee; Yoon-sik Kim; Chang-Gue Son; Jung-Hyo Cho; Hwa-Seung Yoo; Jonghoon Lee; Juyoung Ryu; Namhun Lee;
Page : 259-263
Keywords : gefitinib; geonchilgyebok-jeong; hwanggibujeong-dan; Korean herbal medicine; lung cancer; woohwanggeosa-dan;
Abstract
Abstract Abstract Lung cancer has a high mortality rate and is often diagnosed at the metastatic stage. Gefitinib is a targeted molecular therapeutic drug used to treat patients with non-small-cell lung cancer (NSCLC). Korean herbal medicines may also have therapeutic efficacy against lung cancer, reduce the side effects associated with ch
Other Latest Articles
- Toxicity and Safety Profiles of Methanolic Extract of Pistacia integerrima J. L. Stewart ex Brandis (PI) for Wistar Rats
- Phenol-Rich Compounds Sweet Gel: A Statistically More Effective Antibiotic than Cloxacillin Against Pseudomonas Aeruginosa
- Agarwood Inhibits Histamine Release from Rat Mast Cells and Reduces Scratching Behavior in Mice Effect of Agarwood on Histamine Release and Scratching Behavior
- Assessment of the Toxicity and the Stability of Saeng Mak San by Using Repeated Intravenous Injections in Sprague-Dawley Rats
- Bee Venom (Apis Mellifera) an Effective Potential Alternative to Gentamicin for Specific Bacteria Strains Bee Venom an Effective Potential for Bacteria
Last modified: 2016-09-29 16:29:31